首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   22201篇
  免费   496篇
  国内免费   529篇
耳鼻咽喉   603篇
儿科学   1273篇
妇产科学   399篇
基础医学   2133篇
口腔科学   736篇
临床医学   1324篇
内科学   5029篇
皮肤病学   372篇
神经病学   1541篇
特种医学   585篇
外科学   3673篇
综合类   560篇
一般理论   10篇
预防医学   2200篇
眼科学   498篇
药学   1359篇
  4篇
中国医学   421篇
肿瘤学   506篇
  2024年   10篇
  2023年   60篇
  2022年   78篇
  2021年   122篇
  2020年   106篇
  2019年   131篇
  2018年   167篇
  2017年   75篇
  2016年   154篇
  2015年   111篇
  2014年   196篇
  2013年   108篇
  2012年   2032篇
  2011年   2323篇
  2010年   577篇
  2009年   321篇
  2008年   1827篇
  2007年   2058篇
  2006年   1794篇
  2005年   1946篇
  2004年   1834篇
  2003年   1778篇
  2002年   1665篇
  2001年   1118篇
  2000年   1624篇
  1999年   753篇
  1998年   92篇
  1997年   27篇
  1996年   26篇
  1995年   31篇
  1994年   14篇
  1993年   12篇
  1992年   5篇
  1991年   5篇
  1990年   7篇
  1989年   7篇
  1988年   9篇
  1987年   4篇
  1986年   4篇
  1984年   2篇
  1983年   3篇
  1982年   1篇
  1981年   2篇
  1978年   1篇
  1976年   1篇
  1967年   1篇
  1966年   1篇
  1957年   1篇
  1942年   2篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
目的 分析肝内胆管癌(ICC)病人肝切除术后“教科书式结局”(TO)的影响因素,构建预测TO评分模型。方法 回顾性分析2011年1月至2017年1月东南大学附属中大医院和中国人民解放军东部战区总医院八一医院收治的261例行肝切除术的ICC病人临床病理资料,分析影响TO的独立危险因素,根据危险因素的权重构建预测TO的评分模型。结果 261例ICC病人中,67例(25.7%)术后发生TO。年龄、肝硬化、手术时间和T分期[第8版美国癌症联合委员会(AJCC)癌症分期]为术后TO的独立预测因素。依此4项因素构建的评分模型显示了较好的预测准确性,最佳截断值为-1.9分,其敏感度为67.2%,特异度为62.9%。一致性检验显示其预测概率和实际发生概率有着较好的一致性(χ2=1.350,P=0.853)。结论 基于年龄、肝硬化、手术时间、T分期4个因素建立的评分模型可较准确地预测ICC病人术后TO的可能性,即手术时间短、无肝硬化、肿瘤直径<5 cm的年轻ICC病人肝切除后获得TO的可能性更大。  相似文献   
2.
3.
目的:报道1例因双眼脉冲幅度(OPA)增加发现动脉反流的病例,而后者正是引起OPA增加的原因。设计:病例报道。方法:偶然发现双眼OPA增高,由此发现脉压增高和动脉反流。患者接受动脉瓣膜手术,待动脉脉压恢复正常后评价OPA。结果:动脉脉压高时的双眼OPA为9mmHg,动脉脉压恢复正常后的双眼OPA为3mmHg。结论:动脉脉压增高可以导致OPA增高。眼脉冲幅度增加提示动脉反流@McKee H.D.R.$Hull and East Yorkshire Eye Hospital, Fountain Street, Hull, Uni ted Kingdom @Saldaa M. @Ahad M.A. @张少娟…  相似文献   
4.
肥大细胞是多种介质和细胞因子的产生细胞。它直接或间接参与机体的多种生理和病理过程。近年的研究发现 ,肥大细胞与肾纤维化也有较为密切的关系 ,机制尚不完全清楚。本文就这方面的研究进展作一综述  相似文献   
5.
Background: Volatile anesthetic preconditioning (APC) protects against myocardial ischemia-reperfusion (IR) injury, but the precise mechanisms underlying this phenomenon remain undefined. To investigate the molecular mechanism of APC in myocardial protection, the activation of nuclear factor (NF) [kappa]B and its regulated inflammatory mediators expression were examined in the current study.

Methods: Hearts from male rats were isolated, Langendorff perfused, and randomly assigned to one of three groups: (1) the control group: hearts were continuously perfused for 130 min; (2) the IR group: 30 min of equilibration, 15 min of baseline, 25 min of ischemia, 60 min of reperfusion; and (3) the APC + IR group: 30 min of equilibration, 10 min of sevoflurane exposure and a 5-min washout, 25 min of global ischemia, 60 min of reperfusion. Tissue samples were acquired at the end of reperfusion. NF-[kappa]B activity was determined by electrophoretic mobility shift assay. The NF-[kappa]B inhibitor, I[kappa]B-[alpha], was determined by Western blot analysis. Myocardial inflammatory mediators, including tumor necrosis factor [alpha], interleukin 1, intercellular adhesion molecule 1, and inducible nitric oxide synthase, were also assessed by Western blot analysis.

Results: Nuclear factor [kappa]B-DNA binding activity was significantly increased at the end of reperfusion in rat myocardium, and cytosolic I[kappa]B-[alpha] was decreased. Supershift assay revealed the involvement of NF-[kappa]B p65 and p50 subunits. APC with sevoflurane attenuated NF-[kappa]B activation and reduced the expression of tumor necrosis factor [alpha], interleukin 1, intercellular adhesion molecule 1, and inducible nitric oxide synthase. APC also reduced infarct size and creatine kinase release and improved myocardial left ventricular developed pressure during IR.  相似文献   

6.
Background: Adenosine triphosphate-regulated potassium channels mediate protection against myocardial infarction produced by volatile anesthetics and opioids. We tested the hypothesis that morphine enhances the protective effect of isoflurane by activating mitochondrial adenosine triphosphate-regulated potassium channels and opioid receptors.

Methods: Barbiturate-anesthetized rats (n = 131) were instrumented for measurement of hemodynamics and subjected to a 30 min coronary artery occlusion followed by 2 h of reperfusion. Myocardial infarct size was determined using triphenyltetrazolium staining. Rats were randomly assigned to receive 0.9% saline, isoflurane (0.5 and 1.0 minimum alveolar concentration [MAC]), morphine (0.1 and 0.3 mg/kg), or morphine (0.3 mg/kg) plus isoflurane (1.0 MAC). Isoflurane was administered for 30 min and discontinued 15 min before coronary occlusion. In eight additional groups of experiments, rats received 5-hydroxydecanoic acid (5-HD; 10 mg/kg) or naloxone (6 mg/kg) in the presence or absence of isoflurane, morphine, and morphine plus isoflurane.

Results: Isoflurane (1.0 MAC) and morphine (0.3 mg/kg) reduced infarct size (41 +/- 3%; n = 13 and 38 +/- 2% of the area at risk; n = 10, respectively) as compared to control experiments (59 +/- 2%; n = 10). Morphine plus isoflurane further decreased infarct size to 26 +/- 3% (n = 11). 5-HD and naloxone alone did not affect infarct size, but abolished cardioprotection produced by isoflurane, morphine, and morphine plus isoflurane.  相似文献   

7.
杜仲Eucommia ulmoids Oliv.始载于《神农本草经》,列为上品,味辛平,主腰脊痛,补中益精气,坚筋骨,强志,除下阴痒湿,小便余沥。久服轻身耐老。一名思仙,生山谷。历代炮炙方法很多,但沿用至今很少,缪希雍渭:“既识药矣,宜习修事。雷公炮制,固为大法,或有未尽,可以意通,必期躬亲,勿图苟且。”炮制为中医临床提供合格用药及中成药生产提供合格原料药,因此炮制必须达到临床使用要求,确保用药安全。现将历代对杜仲炮制方法和研究论述如下。  相似文献   
8.
9.
目的:探讨反应停治疗难治性多发性骨髓瘤(MM)的临床疗效。方法:对6例难治疗性多发性骨髓瘤应用反应停治疗后的临床资料进行分析,并结合文献复习,为该病的治疗提供一条思路。结果:1例患者达完全缓解;1例患者达部分缓解;1例进步,血清M蛋白减少35%、骨痛明显减轻、血沉降低40%、血红蛋白上升20g/L;2例无效;1例死亡。结论:反应停对多发性骨髓瘤有较好的疗效,不良反应可以耐受且不产生骨髓抑制:抗血管新生是其主要疗效机制。  相似文献   
10.
Background: A multidisciplinary effort was undertaken to determine whether patients could safely bypass the postanesthesia care unit (PACU) after same-day surgery by moving to an earlier time point evaluation of recovery criteria.

Methods: A prospective, outcomes research study with a baseline month, an intervention month, and a follow-up month was designed. Five surgical centers (three community-based hospitals and two freestanding ambulatory surgical centers) were utilized. Two thousand five hundred eight patients were involved in the baseline period, and 2,354 were involved in the follow-up period. Outcome measures included PACU bypass rates and adverse events. Intervention consisted of a multidisciplinary educational program and routine feedback reports.

Results: The overall PACU bypass rate (58%) was significantly different from baseline (15.9%, P < 0.001), for patients to whom a general anesthetic was administered (0.4-31.8%, P < 0.001), and for those given other anesthetic techniques (monitored anesthesia care, regional or local anesthetics; 29.1-84.2%, P < 0.001). During the follow-up period, the average (SD) recovery duration for patients who bypassed the PACU was significantly shorter compared to that for patients who did not bypass, 84.6 (61.5) versus 175.1 (98.8) min, P < 0.001, with no change in patient outcome. Patients receiving only short-acting anesthetics were 78% more likely (P < 0.002) to bypass the PACU after adjusting for various surgical procedures.  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号